IONQ.NYSEIonq, INC

Form 4: IonQ Executive Chair Sells Shares Under 10b5-1 Plan

Sentiment:

Statement of Changes in Beneficial Ownership


IonQ Director Robert T. Cardillo exercised options and sold 2,500 shares of common stock at a significant premium under a pre-arranged trading plan.

Summary

  • Robert T. Cardillo, Director and Executive Chair of IonQ Federal, executed a cashless exercise of stock options on April 16, 2026.
  • The transaction involved exercising 2,500 options at a strike price of 11.24 USD and immediately selling the resulting shares at 44.90 USD.
  • The sale was conducted under a Rule 10b5-1 trading plan, which was established on March 12, 2025, and amended on June 13, 2025.
  • Following these transactions, Cardillo maintains direct ownership of 139,967 shares of IonQ common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; while it is a sale, it is small relative to the total holding and was executed via a pre-planned 10b5-1 program.

Positives

  • The reporting person retains a substantial stake of 139,967 shares, indicating continued alignment with shareholder interests.
  • The sale price of 44.90 USD represents a 300 percent gain over the exercise price of 11.24 USD.
  • The use of a Rule 10b5-1 plan provides transparency and mitigates concerns regarding insider trading based on non-public information.

Negatives

  • Insider selling, even when planned, can occasionally be perceived by the market as a lack of confidence in immediate further price appreciation.

Risks

  • Market volatility could affect the execution of future tranches of the 10b5-1 plan.
  • The company stock price must remain above the 11.24 USD exercise price for the remaining 12,547 options to remain in the money.

Future Outlook

The reporting person has 12,547 derivative securities (options) remaining, which will continue to vest annually through February 2027, suggesting potential future sales under the established trading plan.

Management Comments

  • The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025.

Industry Context

StockSavvy.ai notes that insider activity in the high-growth quantum computing sector is closely watched; IonQ's use of 10b5-1 plans is standard practice for executives in volatile tech industries to manage personal liquidity without signaling market timing.

Comparison to Industry Standards

  • The exercise price of 11.24 USD is competitive compared to early-stage grant prices seen at peers like Rigetti Computing or D-Wave Systems.
  • The sale at 44.90 USD reflects a valuation multiple often seen in high-growth tech firms reaching commercial milestones, though it is significantly higher than IonQ's historical trading averages.

Related Party Transactions

  • The reporting person is a Director and Executive Chair of IonQ Federal, a subsidiary or division of the issuer.

Stakeholder Impact

  • Minimal impact on shareholders due to the small volume of shares sold relative to the company's total market capitalization.

Next Steps

  • Continued vesting of remaining 12,547 options on February 26, 2027.

Key Dates

DateDescription
2025-02-26Initial vesting date for one-third of the stock options.
2025-03-12Adoption date of the Rule 10b5-1 trading plan.
2025-06-13Amendment date of the Rule 10b5-1 trading plan.
2026-04-16Date of the reported option exercise and stock sale.
2026-04-17Date the Form 4 was signed and filed.
2034-02-26Expiration date for the stock options mentioned in the filing.

Recommendation

hold

The insider sale is routine and planned, and the executive maintains a large long-term position, suggesting no immediate change in company fundamentals.

Keywords

IonQ, IONQ, Insider Trading, Form 4, Stock Options, Quantum Computing, Robert Cardillo, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.